Condition
Biceps Tendonitis
Total Trials
3
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 55/100
Termination Rate
33.3%
1 terminated out of 3 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
200%
2 of 1 completed with results
Key Signals
2 with results50% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Terminated1
Withdrawn1
Completed1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (3)
Showing 3 of 3 trials
NCT02591953Not ApplicableTerminatedPrimary
Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections
NCT02192073Not ApplicableWithdrawnPrimary
Analysis of Suprapectoral and Subpectoral Biceps Tenodesis
NCT02741713Phase 3CompletedPrimary
Analgesic Benefit of PECS Blocks for Biceps Tenodesis Shoulder Surgery
Showing all 3 trials